AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
9.75
-0.20 (-2.01%)
Feb 21, 2025, 4:00 PM EST - Market closed
AVITA Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2016 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
Cash & Equivalents | 14.05 | 22.12 | 18.16 | 55.51 | 110.75 | Upgrade
|
Short-Term Investments | 21.84 | 66.94 | 61.18 | 29.65 | - | Upgrade
|
Cash & Short-Term Investments | 35.89 | 89.06 | 79.34 | 85.16 | 110.75 | Upgrade
|
Cash Growth | -59.71% | 12.24% | -6.83% | -23.10% | 50.39% | Upgrade
|
Accounts Receivable | 11.84 | 7.69 | 3.53 | 3.43 | 7.4 | Upgrade
|
Other Receivables | 0.12 | 0.23 | 1.18 | 0.09 | 0.48 | Upgrade
|
Receivables | 11.96 | 7.92 | 4.71 | 3.51 | 7.88 | Upgrade
|
Inventory | 7.27 | 5.6 | 2.13 | 2.13 | 1.65 | Upgrade
|
Prepaid Expenses | 1.88 | 1.43 | 0.92 | 1.12 | 0.85 | Upgrade
|
Restricted Cash | - | - | - | 0.2 | 0.2 | Upgrade
|
Other Current Assets | - | - | 0.36 | 0 | - | Upgrade
|
Total Current Assets | 57 | 104.01 | 87.46 | 92.13 | 121.33 | Upgrade
|
Property, Plant & Equipment | 13.59 | 4.32 | 2.05 | 2.81 | 2.94 | Upgrade
|
Long-Term Investments | - | - | 6.93 | 19.69 | - | Upgrade
|
Other Intangible Assets | 5.57 | 0.49 | 0.47 | 0.44 | 0.47 | Upgrade
|
Long-Term Deferred Charges | - | - | - | 0.5 | 0.61 | Upgrade
|
Other Long-Term Assets | 3.55 | 2.83 | 1.36 | 0.44 | 0.15 | Upgrade
|
Total Assets | 79.71 | 111.64 | 98.26 | 116.02 | 125.5 | Upgrade
|
Accounts Payable | 6.29 | 3.79 | 3 | 2.71 | 3.12 | Upgrade
|
Accrued Expenses | 12.55 | 8.14 | 6.7 | 5.36 | 3.32 | Upgrade
|
Current Portion of Leases | 0.9 | 0.9 | 0.61 | 0.72 | 0.7 | Upgrade
|
Current Unearned Revenue | 0.03 | 0.03 | - | - | - | Upgrade
|
Other Current Liabilities | 0.39 | 0.34 | 0.38 | 0.36 | 0.25 | Upgrade
|
Total Current Liabilities | 20.16 | 13.2 | 10.69 | 9.15 | 7.39 | Upgrade
|
Long-Term Debt | 42.25 | 39.81 | - | - | - | Upgrade
|
Long-Term Leases | 2.84 | 1.7 | 0.31 | 0.92 | 0.88 | Upgrade
|
Long-Term Unearned Revenue | 0.32 | 0.36 | 0.7 | 0.95 | 1.08 | Upgrade
|
Other Long-Term Liabilities | 9.65 | 7.51 | 1.83 | 0.38 | 0.5 | Upgrade
|
Total Liabilities | 75.21 | 62.58 | 13.52 | 11.39 | 9.85 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 367.57 | 350.04 | 339.83 | 332.48 | 328.89 | Upgrade
|
Retained Earnings | -359.81 | -297.97 | -262.59 | -235.92 | -221.5 | Upgrade
|
Comprehensive Income & Other | -3.26 | -3.02 | 7.5 | 8.06 | 8.26 | Upgrade
|
Shareholders' Equity | 4.5 | 49.06 | 84.74 | 104.62 | 115.66 | Upgrade
|
Total Liabilities & Equity | 79.71 | 111.64 | 98.26 | 116.02 | 125.5 | Upgrade
|
Total Debt | 45.99 | 42.41 | 0.92 | 1.64 | 1.58 | Upgrade
|
Net Cash (Debt) | -10.1 | 46.65 | 85.35 | 103.21 | 109.17 | Upgrade
|
Net Cash Growth | - | -45.35% | -17.30% | -5.45% | 53.35% | Upgrade
|
Net Cash Per Share | -0.39 | 1.84 | 3.41 | 4.24 | 4.81 | Upgrade
|
Filing Date Shares Outstanding | 26.36 | 25.71 | 25.3 | 24.93 | 24.9 | Upgrade
|
Total Common Shares Outstanding | 26.35 | 25.68 | 25.21 | 24.93 | 24.9 | Upgrade
|
Working Capital | 36.84 | 90.81 | 76.77 | 82.99 | 113.94 | Upgrade
|
Book Value Per Share | 0.17 | 1.91 | 3.36 | 4.20 | 4.65 | Upgrade
|
Tangible Book Value | -1.07 | 48.57 | 84.28 | 104.18 | 115.18 | Upgrade
|
Tangible Book Value Per Share | -0.04 | 1.89 | 3.34 | 4.18 | 4.63 | Upgrade
|
Machinery | 6.2 | 3.02 | 1.97 | 1.88 | 1.81 | Upgrade
|
Construction In Progress | 0.44 | 0.09 | 0.26 | 0.03 | 0.05 | Upgrade
|
Leasehold Improvements | 4.61 | 0.37 | 0.26 | 0.24 | 0.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.